# aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

> **NCT07741890** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The Christ Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Angina With Non-Obstructive Coronary Artery Disease
- Coronary Microvascular Dysfunction (CMD)

## Interventions

- **DRUG:** Dapagliflozin (10mg Tab)
- **DRUG:** Placebo ( FE)

## Key facts

- **NCT ID:** NCT07741890
- **Lead sponsor:** The Christ Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741890, "aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*